Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Marta A Tarczyluk & Jonathan D Cooper. (2015) Investigative and emerging treatments for Batten disease. Expert Opinion on Orphan Drugs 3:9, pages 1031-1045.
Read now
Read now
Gregory M Pastores. (2003) Enzyme therapy for the lysosomal storage disorders: principles, patents, practice and prospects. Expert Opinion on Therapeutic Patents 13:8, pages 1157-1172.
Read now
Read now
Articles from other publishers (30)
N. Vishal Gupta, K. Trideva Sastri, M. Sharadha, Souvik Chakraborty, V. Balamuralidhara & Amit Alexander. 2022. Drug Delivery Systems for Metabolic Disorders. Drug Delivery Systems for Metabolic Disorders
281
299
.
Arnold E. Stütz, Martin Thonhofer, Patrick Weber, Andreas Wolfsgruber & Tanja M. Wrodnigg. (2021)
Pharmacological Chaperones for β‐Galactosidase Related to G
M1
‐Gangliosidosis and Morquio B: Recent Advances
. The Chemical Record 21:11, pages 2980-2989.
Crossref
Crossref
Christopher J. Folts, Nicole Scott-Hewitt, Christoph Pröschel, Margot Mayer-Pröschel & Mark Noble. (2016) Lysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular Toxicity. PLOS Biology 14:12, pages e1002583.
Crossref
Crossref
Gui-shan Jin, Gui-dong Zhu, Zhi-gang Zhao & Fu-sheng Liu. (2011) VP22 enhances the expression of glucocerebrosidase in human Gaucher II fibroblast cells mediated by lentiviral vectors. Clinical and Experimental Medicine 12:3, pages 135-143.
Crossref
Crossref
Ernesto A. SalegioLluis SamaranchRussell W. JenkinsChristopher J. ClarkeClementine LamarreJanine BeyerAdrian P. KellsJohn BringasWaldy San SebastianR. Mark RichardsonKate H. RosenbluthYusuf A. HannunKrystof S. BankiewiczJohn Forsayeth. (2012) Safety Study of Adeno-Associated Virus Serotype 2-Mediated Human Acid Sphingomyelinase Expression in the Nonhuman Primate Brain. Human Gene Therapy 23:8, pages 891-902.
Crossref
Crossref
Keri L. Nowend, Alison N. Starr-Moss & Keith E. Murphy. (2011) The function of dog models in developing gene therapy strategies for human health. Mammalian Genome 22:7-8, pages 476-485.
Crossref
Crossref
E. Aguilar SalegioA.P. KellsR.M. RichardsonP. HadaczekJ. ForsayethJ. BringasS.P. SardiM.A. PassiniL.S. ShihabuddinS.H. ChengM.S. FiandacaK.S. Bankiewicz. (2010) Magnetic Resonance Imaging-Guided Delivery of Adeno-Associated Virus Type 2 to the Primate Brain for the Treatment of Lysosomal Storage Disorders. Human Gene Therapy 21:9, pages 1093-1103.
Crossref
Crossref
Kim M. Hemsley & John J. Hopwood. (2010) Lessons learnt from animal models: pathophysiology of neuropathic lysosomal storage disorders. Journal of Inherited Metabolic Disease 33:4, pages 363-371.
Crossref
Crossref
Pascal Guggenbuhl, Bernard Grosbois & G?rard Chal?s. (2008) La maladie de Gaucher. Revue du Rhumatisme 75:3, pages 198-206.
Crossref
Crossref
Pascal Guggenbuhl, Bernard Grosbois & G?rard Chal?s. (2008) Gaucher disease. Joint Bone Spine 75:2, pages 116-124.
Crossref
Crossref
Ellen Sidransky, Mary E. LaMarca & Edward I. Ginns. (2007) Therapy for Gaucher disease: Don?t stop thinking about tomorrow. Molecular Genetics and Metabolism 90:2, pages 122-125.
Crossref
Crossref
Kerry Anne McEachern, Jennifer B. Nietupski, Wei-Lien Chuang, Donna Armentano, Jennifer Johnson, Elizabeth Hutto, Gregory A. Grabowski, Seng H. Cheng & John Marshall. (2006) AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease. The Journal of Gene Medicine 8:6, pages 719-729.
Crossref
Crossref
Ronald J. Mandel, Fredric P. Manfredsson, Kevin D. Foust, Aaron Rising, Sharon Reimsnider, Kevin Nash & Corinna Burger. (2006) Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. Molecular Therapy 13:3, pages 463-483.
Crossref
Crossref
Mario A Cabrera‐Salazar & John A Barranger. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Eun Young Kim, Young Bin Hong, Zhennan Lai, Youl-Hee Cho, Roscoe O. Brady & Sung-Chul Jung. (2005) Long-term expression of the human glucocerebrosidase genein vivo after transplantation of bone-marrow-derived cells transformed with a lentivirus vector. The Journal of Gene Medicine 7:7, pages 878-887.
Crossref
Crossref
Peter Staib & Pia Hartmann. 2005. Medizinische Therapie 2005|2006. Medizinische Therapie 2005|2006
315
336
.
Ole Kristian Greiner-Tollersrud & Thomas Berg. 2005. Lysosomes. Lysosomes
60
73
.
Marc C. Patterson & Frances Platt. (2004) Therapy of Niemann–Pick disease, type C. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1685:1-3, pages 77-82.
Crossref
Crossref
Young Bin Hong, Eun Young Kim, Han-Wook Yoo & Sung-Chul Jung. (2004) Feasibility of gene therapy in Gaucher disease using an adeno-associated virus vector. Journal of Human Genetics 49:10, pages 536-543.
Crossref
Crossref
Eun Young Kim, Young Bin Hong, Zhennan Lai, Hyon J Kim, Youl-Hee Cho, Roscoe O Brady & Sung-Chul Jung. (2004) Expression and secretion of human glucocerebrosidase mediated by recombinant lentivirus vectors in vitro and in vivo: implications for gene therapy of Gaucher disease. Biochemical and Biophysical Research Communications 318:2, pages 381-390.
Crossref
Crossref
N. Matthew Ellinwood, Charles H. Vite & Mark E. Haskins. (2004) Gene therapy for lysosomal storage diseases: the lessons and promise of animal models. The Journal of Gene Medicine 6:5, pages 481-506.
Crossref
Crossref
Markus Hildinger & Alberto Auricchio. (2004) Advances in AAV-mediated gene transfer for the treatment of inherited disorders. European Journal of Human Genetics 12:4, pages 263-271.
Crossref
Crossref
DP Germain. (2004) Gaucher's disease: a paradigm for interventional genetics. Clinical Genetics 65:2, pages 77-86.
Crossref
Crossref
J. Gärtner. 2004. Therapie der Krankheiten im Kindes- und Jugendalter. Therapie der Krankheiten im Kindes- und Jugendalter
1619
1626
.
S H Cheng & A E Smith. (2008) Gene therapy progress and prospects: gene therapy of lysosomal storage disorders. Gene Therapy 10:16, pages 1275-1281.
Crossref
Crossref
Frances M. Platt, Mylvaganam Jeyakumar, Ulrika Andersson, Tanya Heare, Raymond A. Dwek & Terry D. Butters. (2003) Substrate reduction therapy in mouse models of the glycosphingolipidoses. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 358:1433, pages 947-954.
Crossref
Crossref
K. Mirnics, F. A. Middleton, J. N. Pierri, D. A. Lewis & Pat Levitt. 2003. Neurosciences at the Postgenomic Era. Neurosciences at the Postgenomic Era
45
63
.
Aubrey D.N.J de Grey. (2002) Bioremediation meets biomedicine: therapeutic translation of microbial catabolism to the lysosome. Trends in Biotechnology 20:11, pages 452-455.
Crossref
Crossref
M. Jeyakumar, T. D. Butters, R. A. Dwek & F. M. Platt. (2002) Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis. Neuropathology and Applied Neurobiology 28:5, pages 343-357.
Crossref
Crossref
John Marshall, Kerry Anne McEachern, Julie A.Cavanagh Kyros, Jennifer B Nietupski, Tracey L Budzinski, Robin J Ziegler, Nelson S Yew, Jennifer Sullivan, Abraham Scaria, Nico van Rooijen, John A Barranger & Seng H Cheng. (2002) Demonstration of Feasibility of In Vivo Gene Therapy for Gaucher Disease Using a Chemically Induced Mouse Model. Molecular Therapy 6:2, pages 179-189.
Crossref
Crossref